PHD Biosciences (PHD) is a New York City based biosciences company developing a pipeline of dermatological products for diseases with high unmet medical need. The PHD products are unique because they utilize our patented and proprietary extension applicator to facilitate the application of treatment formula to the harder-to-reach areas of the back, shoulders, and lower extremities. The PHD research pipeline is complimented by revenue from 15 awards that total more than $9.5 million since 2011. These include: several Small Business Innovation Research (SBIR) awards from the National Cancer Institute (NCI), and National Heart Lung and Blood Institute (NHLBI), a Small Business Technology Transfer (STTR) award from the NCI, funding from the Avon Foundation for Women, and three Center for Advanced Technology awards from New York State.
PHD DERMATOLOGY ASSETS
The PHD dermatology pipeline comprises several products that are being developed through 505(b)(2) New Drug Applications for a variety of indications. Please see the INNOVATIONS page for information.
OTC AND SKIN CARE PRODUCTS
The over the counter (OTC) drug and skin care commercial product portfolio is managed by an independent team at PHD Skin Care. Please visit www.phdskincare.com, or email firstname.lastname@example.org for information.